Li Xie

Li Xie currently serves as the Executive Director of Biostatistics at Apogee Therapeutics, having joined the company in November 2023. Prior to this role, Xie was the Director of Biostatistics at EQRx from June 2021 to November 2023, where Xie led biostatistical efforts in Inflammation and Immunology. Xie's extensive experience also includes a tenure at Eli Lilly and Company from March 2002 to June 2021 as a Senior Research Scientist, providing statistical leadership in drug development for Immunology and Endocrinology. Li Xie holds a Master of Science degree in Statistics from Iowa State University, earned between 1999 and 2001.